Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ranibizumab combined with transpupillary thermotherapy versus sham thermotherapy in neovascular age-related macular degeneration
2007-005462-12Phase 2Active
- Sponsor
- St. Eriks Eye Hospital
- Start
- Oct 2007
- Modality
- Antibody Fragments → Engineered Antibody Formats → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 2, randomised trial of ranibizumab in exudative macular degeneration (2 arms), sponsored by St. Eriks Eye Hospital. Started Oct 2007; status: active.
02
Drugs
ranibizumab
03
Conditions
exudative macular degeneration
Beyond the preview
Go deeper on 2007-005462-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-005462-12.